Teva Pharmaceutical Industries Limited (TEVA)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 09:34AM EDT. Market open.
| Previous close | 15.74 |
| Open | 14.57 |
| Bid | 15.65 x 800 |
| Ask | 15.72 x 3000 |
| Day's range | 15.53 - 15.77 |
| 52-week range | 7.09 - 16.13 |
| Volume | |
| Avg. volume | 9,815,675 |
| Market cap | 17.668B |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 27 Nov 2017 |
| 1y target est | N/A |
- Simply Wall St.
Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Teva Pharmaceutical Industries ( NYSE:TEVA ) First Quarter 2024 Results Key Financial Results Revenue: US$3.82b (up...
- Investor's Business Daily
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Teva stock surged Wednesday after the company beat first-quarter views and unveiled promising results from its schizophrenia drug study.
- Barrons.com
Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.
© 2024 Yahoo. All rights reserved.